Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Year: March 05, 2025